ANALYSIS OF T-HELPER SUBSETS OF PERIPHERAL BLOOD OF PATIENTS WITH CHRONIC HEPATITIS C EXPRESSING CHEMOKINE RECEPTORS CXCR3 AND CCR6 AND ACTIVATION MARKERS CD38 AND HLA-DR

Cover Page

Cite item

Abstract

Abstract. In case of hepatitis C the adequate adaptive immune response depends on T-helper lymphocyte subsets and recruiting specific T cells in the site of infection. The purpose of the study was to assess changes in subpopulations of T-helper cells bearing chemokine receptor CXCR3 and CCR6 and activation markers CD38 and HLA-DR in peripheral blood of patients with chronic hepatitis C (n = 19) and healthy donors (n = 32). The T-helper phenotype was assessed by flow cytometry using a combination of monoclonal antibodies HLA-DR-FITC/CD38-PE/CD3-ECD/CCR6-PE-Cy7/CXCR3-APC/CD4-APC-Cy7. It was demonstrated reduction of CD38+ subset, increase of CXCR3+ and CCR6+ subsets of T-helper cells in particular CD3+CD4+ CXCR3+CCR6+ cells and importance of joint determination of the chemokine receptors CXCR3 and CCR6 and the activation markers CD38 and HLA-DR compared to their separate analysis in chronic hepatitis C.

About the authors

D. S. Elezov

St. Petersburg Pasteur Institute, St. Petersburg

Author for correspondence.
Email: elezovds@yahoo.com

Researcher, Laboratory of Molecular Immunology and Seroepidemiology

197101, Russian Federation, St. Petersburg, Mira str., 14

Russian Federation

I. V. Kudryavtsev

Institute of Experimental Medicine of the North West Branch of the Russian Academy of Medical Sciences, St. Petersburg; Far East Federal University, Vladivostok; St. Petersburg State University, St. Petersburg

Email: elezovds@yahoo.com

PhD (Biology), Senior Researcher, Department of Immunology, Institute of Experimental Medicine of the North West Branch of the Russian Academy of Medical Sciences; Associated Professor, Department of Fundamental Medicine, Far East Federal University; Associated Professor, Department of Cytology and Histology, St. Petersburg State University

Russian Federation

N. A. Arsentieva

St. Petersburg Pasteur Institute, St. Petersburg

Email: elezovds@yahoo.com
Researcher, Laboratory of Molecular Immunology and Seroepidemiology Russian Federation

A. V. Semenov

St. Petersburg Pasteur Institute, St. Petersburg

Email: elezovds@yahoo.com
PhD (Biology), Head of Laboratory of Immunology and Epidemiology of HIV infection Russian Federation

E. V. Esaulenko

St. Petersburg State Pediatric Medical University, St. Petersburg

Email: elezovds@yahoo.com
PhD, MD (Medicine), Professor, Head of the Department of Infectious Disease of Adults and Epidemiology Russian Federation

V. V. Basina

St. Petersburg State Pediatric Medical University, St. Petersburg

Email: elezovds@yahoo.com
Assistant Professor, Department of Infectious Disease of Adults and Epidemiology Russian Federation

Areg A. Totolian

St. Petersburg Pasteur Institute, St. Petersburg

Email: elezovds@yahoo.com

PhD, MD (Medicine), Professor, Corresponding Member of the Russian Academy of Medical Sciences, Deputy Director
of Research

Russian Federation

References

  1. Арсентьева Н.А., Семенов А.В., Тотолян А.А. Роль полиморфизма генов цитокинов при вирусном гепатите С // Инфекция и иммунитет. — 2012. — Т. 2, № 4. — С. 687–698. Arsent`eva N.A., Semenov A.V., Totolian A.A. Rol` polimorfizma genov tsitokinov pri virusnom gepatite S [The role of cytokine gene polymorphism in hepatitis C virus infection]. Infektsiya i immunitet — Infection and Immunity, 2012, vol. 2, no. 4, pp. 687–698.
  2. Вирусные гепатиты в Российской Федерации. Аналитический обзор. 8 выпуск / Под ред. В.И. Покровского, А.Б. Жебруна. — СПб.: ФБУН НИИЭМ имени Пастера, 2011. — 116 с. Virusnye gepatity v Rossiyskoy Federatsii. Analiticheskiy obzor. 8 vypusk (Pod red. V.I. Pokrovskogo, A.B. Zhebruna) [Viral hepatitis in Russian Federation. Analytical review. Issue 8 (Ed. Pokrovskiy V.I., Zhebrun A.B.)]. St. Petersburg Pasteur Institute, 2011. 116 p.
  3. Жданов К.В., Гусев Д.А., Чирский B.C., Сысоев К.А., Якубовская Л.А., Шахманов Д.М., Тотолян А.А. Хроническая HCV-инфекция и экспрессия мРНК СС-хемокинов и их рецепторов // Журнал микробиологии, эпидемиологии и иммунобиологии. — 2008. — № 4. — С. 73–78. Zhdanov K.V., Gusev D.A., Chirskiy B.C., Sysoev K.A., Yakubovskaya L.A., Shakhmanov D.M., Totolian A.A. Hronicheskaya HCV-infektsiya i ekspressiya mRNK SS-khemokinov i ikh retseptorov [Chronic HCV infection and mRNA expression of CC-chemokines and their receptors]. Zhurnal mikrobiologii, epidemiologii i immunobiologii — Journal of Microbiology, Epidemiology and Immunobiology, 2008, vol. 4, pp. 73–78.
  4. Сысоев К.А., Чухловин А.Б., Тотолян А.А. Диагностическая роль определения хемокинов и их рецепторов при хроническом гепатите С // Клин. лабораторная диагностика. — 2013. — № 2. — С. 23–29. Sysoev K.A., Chukhlovin A.B., Totolian A.A. Diagnosticheskaya rol` opredeleniya khemokinov i ikh retseptorov pri khronicheskom gepatite S [The diagnostic role of chemokines and their receptors in chronic hepatitis C]. Klinicheskaya laboratornaya diagnostika — Clinical Laboratory Diagnostics, 2013, vol. 2, pp. 23–29.
  5. Сысоев К.А., Чухловин А.Б., Шахманов Д.М., Жданов К.В., Тотолян А.А. Профиль цитокинов и хемокинов в плазме крови пациентов с хроническим гепатитом С // Инфекция и иммунитет. — 2013. — Т. 3, № 1. — С. 49–58. Sysoev K.A., Chukhlovin A.B., Shakhmanov D.M., Zhdanov K.V., Totolian A.A. Profil` tsitokinov i khemokinov v plazme krovi patsientov s khronicheskim gepatitom S [Cytokines and chemokines in the blood plasma of patients with chronic hepatitis C]. Infektsiya i immunitet — Infection and Immunity, 2013, vol. 3, no. 1, pp. 49–58.
  6. Хайдуков С.В., Байдун Л.А., Зурочка А.В., Тотолян А.А. Стандартизованная технология «Исследование субпопуляционного состава лимфоцитов периферической крови с применением проточных цитофлюориметров-анализаторов» (Проект) // Медицинская иммунология. — 2012. — Т. 14, № 3. — С. 255–268. Khaidukov S.V., Baydun L.A., Zurochka A.V., Totolian A.A. Standartizovannaya tekhnologiya “Issledovanie subpopulyatsionnogo sostava limfotsitov perifericheskoy krovi s primeneniem protochnykh tsitoflyuorimetrov-analizatorov” (Proekt) [Standard technology “Flow cytometric immunophenotyping of peripheral blood lymphocytes” (Draft version)]. Meditsinskaya immunologiya — Medical Immunology, 2012, vol. 12, no. 3, pp. 255–268.
  7. Annunziato F., Cosmi L., Liotta F., Maggi E., Romagnani S. The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation. Int. Immunol., 2008, vol. 20, pp. 1361–1368.
  8. Bromley S., Mempel T., Luster A. Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat. Immunol., 2008, vol. 9, pp. 970–980.
  9. Butera D., Marukian S., Iwamaye A., Hembrador E., Chambers T., Di Bisceqlie A., Charles E., Tatal A., Jacobson I., Rice C., Dustin L. Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C. Blood, 2005, vol. 106, pp. 1175–1182.
  10. Casrouge A., Decalf J., Ahloulay M., Lababidi C., Mansour G., Vallet-Pichard A., Mallet V., Mottez E., Mapes J., Fontanet A., Pol S., Albert M. Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV. J. Clin. Invest., 2011, vol. 121, pp. 308–317.
  11. Crome S., Clive B., Wang A, Kang C, Chow V., Yu J., Lai A., Ghahary A., Broady R., Levings M. Inflammation effects of ex vivo human Th17 cells are suppressed by regulatory T cells. J. Immunol., 2010, vol. 185, pp. 3199–3208.
  12. Diago M., Castellano G., Garcia-Samaniego J., Perez C., Fernandez I., Romero M., Iacono O., Garcia-Monson C. Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C. Gut, 2006, vol. 55, pp. 374–379.
  13. Gonzales V., Falconer K., Blom K., Reichard O., Morn B., Laursen A., Weis N., Alaeus A., Sandberq J. High levels of chronic activation in the T-cell compartments of patients coinfected with hepatitis C virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin treatment. J. Virol., 2009, vol. 83, pp. 11407–11411.
  14. Groom J., Luster A. CXCR3 in T cell function. Exp. Cell Res., 2011, vol. 317, pp. 620–631.
  15. Lauer G., Walker B. Hepatitis C virus infection. N. Engl. J. Med., 2001, vol. 345, pp. 41–52.
  16. Maecker H., McCoy P., Nussenblatt R. Standardizing immunophenotyping for the human immunology project. Nat. Rev. Immunol., 2012, vol. 12, pp. 191–200.
  17. Oo Y., Banz V., Kavanagh D., Liaskou E., Withers D., Humphreys E., Reynolds G., Lee-Turner L., Kalia N., Hubscher S., Klenerman P., Eksteen B., Adams D. CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver. J. Hepatol., 2012, vol. 57, pp. 1044–1051.
  18. Oo Y., Shetty S., Adams D. The role of chemokines in the recruitment of lymphocytes to the liver. Dig. Dis., 2010, vol. 28, pp. 31–44.
  19. Zeremski M., Petrovic L., Talal A. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection. J. Viral Hepat., 2007, vol. 14, pp. 675–687.

Copyright (c) 2014 Elezov D.S., Kudryavtsev I.V., Arsentieva N.A., Semenov A.V., Esaulenko E.V., Basina V.V., Totolian A.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies